Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding 'Corrigendum to Integrated Annual Report for the 35th Annual General Meeting for the Financial Year 2024-25'.
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has issued a corrigendum to fix typographical errors in its Integrated Annual Report for FY 2024-25, which was originally shared with shareholders on September 6, 2025. On Page 5, the company clarified the appointment of Mr. Virendra G. Bhatt as Scrutinizer for e-voting and confirmed that the Register of Members will remain closed from September 23 to September 29, 2025. On Page 8, the e-voting end date was corrected from September 28, 2024 to September 28, 2025, with the voting window running from September 26-28, 2025 and the cut-off date set as September 22, 2025. The company clarified that these errors do not impact the financial statements for the year ended March 31, 2025, and the corrected report has been uploaded to its website.
This is a routine administrative correction and does not change any financial figures or business outcomes. Shareholders should refer to the updated report on the company's website before the AGM, but there is no material impact on the stock or investment thesis.